Today: 20 May 2026
Nike stock climbs as BTIG tags $100 target, UBS sees stronger brand signals
5 January 2026
1 min read

Nike stock climbs as BTIG tags $100 target, UBS sees stronger brand signals

New York, Jan 5, 2026, 13:28 EST — Regular session

  • Nike shares were up about 2.5% at $64.89 in afternoon trading.
  • BTIG named Nike its top large-cap consumer pick for 2026 with a $100 price target; UBS kept a Neutral rating and a $62 target.
  • Traders are looking ahead to Nike’s next quarterly report, estimated for March 19.

Nike, Inc. (NKE) shares rose about 2.5% to $64.89 on Monday, after fresh analyst commentary highlighted improving brand signals and a 2026 catalyst set. The stock traded between $63.27 and $65.36 in the session.

The notes matter because investors are trying to gauge whether Nike’s turnaround is gaining traction early in 2026, after a period of uneven demand and margin pressure. Wall Street is watching for signs that product refreshes and tighter distribution can lift sales without forcing deeper discounts.

For traders, the near-term debate is timing. A long-dated recovery story does little for a stock if the next couple of quarters show weak pricing power or slow-moving inventories.

BTIG analyst Robert Drbul named Nike his top large-cap consumer pick for 2026 and set a $100 price target — an analyst’s estimate of where a stock could trade over the next year. He pointed to Nike’s product pipeline and a boost from the 2026 World Cup, and said Nike could ultimately lift operating margin — operating profit as a share of sales — back above 12% from around 6.5% in 2025.

UBS struck a more cautious tone, keeping a Neutral rating and a $62 price target after its latest global sportswear survey showed Nike’s brand remains strong and is improving year on year, the bank said. UBS added that the turnaround could take longer than current market expectations.

Nike’s gains came as Wall Street rallied more broadly, with the S&P 500 up about 0.7% and the Nasdaq up about 0.9%, and consumer-discretionary stocks leading the move. Investors were also bracing for upcoming U.S. nonfarm payrolls data as a gauge for the Federal Reserve’s next steps.

Nike is still trying to repair margins while defending market share against rivals such as On and Hoka owner Deckers. In its last quarterly update, Nike said gross margin fell 300 basis points — three percentage points — and CFO Matthew Friend said U.S. tariffs on key sourcing regions would cost about $1.5 billion this year; sales in China fell 17%. “It is a concern that the China results continue to be so poor,” Morningstar analyst David Swartz said. Reuters

But bullish targets rest on execution. If the inventory clean-up stretches into spring and tariffs keep biting, Nike may struggle to show the margin rebound that optimistic models assume, even if survey work points to resilient brand demand.

Investors now look to Nike’s next results — market calendars estimate an after-close report on March 19 — for updates on holiday-quarter demand, China trends and whether channel changes are easing pressure on gross margin.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES
Previous Story

Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing
Next Story

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Go toTop